查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826912

2025年糖尿病诊断全球市场报告

Diabetes Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，糖尿病诊断市场规模强劲成长，从2024年的253.9亿美元增至2025年的273.1亿美元，复合年增长率为7.6%。预测期内的成长归因于糖尿病盛行率的上升、老年人口的扩大、久坐生活方式的增加、微创诊断技术的普及以及肥胖盛行率的上升。

预计未来几年糖尿病诊断市场规模将强劲成长，2029年将达到364.2亿美元，复合年增长率为7.5%。预测期内的成长可归因于胰岛素帮浦普及率的提高、糖尿病技术的不断进步、不健康生活方式的日益盛行、1型和2型糖尿病盛行率的飙升以及医疗保健基础设施的不断扩展。预测期内的主要趋势包括生物感测器技术的进步、技术进步、诊断技术的进步、个人化和标靶治疗医疗以及体外诊断技术的进步。

糖尿病诊断包括透过测量血糖值和其他相关生物标记来检测和监测糖尿病的程序和测试。这些测试有助于识别异常的葡萄糖代谢，评估糖尿病的风险或存在情况，并制定早期检测、疾病管理和治疗计划。

糖尿病诊断的主要产品类型包括血糖仪、连续血糖监测设备、采血针和试纸。血糖仪是携带式医疗设备，透过分析试纸上的少量血液（通常取自指尖）来测量血糖值。这些设备可用于各种环境，包括医院、诊断中心和居家医疗，以检测第1型糖尿病、第2型糖尿病和妊娠糖尿病。

2025年美国关税及由此引发的贸易紧张局势正对医疗保健产业产生重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品在国内的替代品有限。这些成本上涨给医疗保健预算带来了巨大压力，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。为此，该行业正在采取多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供糖尿病诊断市场统计数据，例如全球市场规模、区域份额、糖尿病诊断市场份额的竞争对手、详细的糖尿病诊断细分市场、市场趋势以及糖尿病诊断行业的商机。本糖尿病诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年7.5%的成长率预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加美国实验室从瑞典和荷兰采购的高效液相层析(HPLC)分析仪和校准标准品的成本，从而加剧糖尿病筛检成本并延迟检测结果。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，关税上涨的影响可能更为广泛。

肥胖症的日益流行预计将在未来几年推动糖尿病诊断市场的成长。肥胖的特征是体内脂肪过度堆积，会增加罹患多种健康疾病的风险，包括心臟病和糖尿病。肥胖症发病率的上升与久坐不动的生活方式、加工食品和高热量食品消费量增加、遗传易感性以及体力活动减少等因素有关。糖尿病诊断在肥胖管理中发挥关键作用，它能够以及早发现胰岛素阻抗和葡萄糖代谢问题，从而及时干预，防止体重增加和相关的健康併发症。例如，2023 年 9 月，美国政府机构疾病管制与预防中心报告称，2022 年有 22 个州的成人肥胖率达到或超过 35%，高于 2021 年的 19 个州。肥胖率的上升促进了糖尿病诊断市场的扩张。

糖尿病诊断市场的公司正在扩大其产品阵容，并专注于开发创新产品，例如妊娠糖尿病诊断工具，以满足对妊娠糖尿病早期发现和管理日益增长的需求。这些工具包括医疗设备和测试，旨在检测和监测孕妇的妊娠糖尿病，通常伴随着血糖测试，例如口服葡萄糖耐受测试（OGTT），以评估身体在怀孕期间如何处理糖。例如，2024 年 8 月，奥地利生物技术公司 DirectSens GmbH 推出了 XpressGT RUO 试剂套件，这是一种用于检测与胰岛素抗性相关的疾病（例如妊娠糖尿病、子宫内膜异位症和肝病）的尖端生物感测器工具。该套件透过测量静脉血液中的 2-羟基丁酸（2-HB）水平来快速提供结果，并与标准临床分析仪相容。这项技术创新可以促进早期诊断并改善全球数百万名患者的健康状况。

2023年9月，美国医疗设备公司雅培实验室有限公司（Abbott Laboratories Ltd.）收购了Bigfoot Biomedical Inc.，具体金额未揭露。此次收购旨在巩固雅培在糖尿病护理领域的地位，扩展其辅理善瞬感（FreeStyle Libre）产品组合，并进一步推进其在互联解决方案方面的发展，以实现更加个性化和精准的糖尿病管理。 Bigfoot Biomedical Inc.是一家总部位于美国的医疗科技公司，专注于打造创新的胰岛素管理解决方案。

糖尿病诊断市场由提供胰岛素敏感性和抗性测试、神经病变检测服务、视网膜病变筛检服务和糖尿病风险评估服务等服务的营业单位所获得的收益所构成。市场价值包括服务提供者销售的或包含在其服务产品中的任何相关商品的价值。糖尿病诊断市场还包括血糖监测设备、糖化血红蛋白 (HbA1c)检测套组和胰岛素帮浦的销售。该市场的价值是指“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球糖尿病诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球糖尿病诊断市场：成长率分析
  • 全球糖尿病诊断市场表现：规模与成长，2019-2024
  • 全球糖尿病诊断市场预测：规模与成长，2024-2029年，2034年
  • 全球糖尿病诊断：总目标市场（TAM）

第六章 市场细分

  • 全球糖尿病诊断市场（按产品类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 血糖仪
  • 连续血糖监测装置
  • 《采血针》
  • 试纸
  • 其他的
  • 全球糖尿病诊断市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 糖尿病I
  • II型糖尿病
  • 妊娠糖尿病
  • 全球糖尿病诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 居家照护环境
  • 其他的
  • 全球糖尿病诊断市场：血糖仪细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 传统血糖监测仪
  • 智慧型血糖仪
  • 蓝牙血糖监测仪
  • 全球糖尿病诊断市场：持续血糖监测设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 穿戴式CGM系统
  • 植入式CGM系统
  • 闪光血糖仪
  • 全球糖尿病诊断市场：采血针细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 免稍后采血针
  • 多用途采血针
  • 全球糖尿病诊断市场：试纸细分、类型、效能及预测（2019-2024、2024-2029、2034）
  • 标准试纸
  • 智慧试纸
  • 全球糖尿病诊断市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • HbA1c 检测检测套组
  • 尿糖试纸
  • 血酮仪

第七章 区域和国家分析

  • 全球糖尿病诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球糖尿病诊断市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 糖尿病诊断市场：竞争格局
  • 糖尿病诊断市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Novartis AG
  • 3M Company
  • Medtronic plc
  • Regeneron Pharmaceuticals Inc.
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated
  • DexCom Inc
  • Santen Pharmaceutical Co. Ltd.
  • Topcon Corporation
  • Tandem Diabetes Care Inc
  • Ypsomed AG
  • LifeScan Inc
  • Nova Biomedical Corporation
  • Ascensia Diabetes Care Holdings AG
  • ARKRAY Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年糖尿病诊断市场：提供新机会的国家
  • 2029年糖尿病诊断市场：细分市场将带来新机会
  • 2029年糖尿病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34033u

Diabetes diagnostics encompasses the methods and tests used to detect and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. These assessments help identify abnormal glucose metabolism, assess diabetes risk or presence, and support early detection, disease management, and treatment planning.

The primary product types in diabetes diagnostics include blood glucose meters, continuous glucose monitoring devices, lancets, test strips, and others. Blood glucose meters are portable medical devices that measure blood sugar levels by analyzing a small drop of blood, usually from a fingertip, placed on a test strip. These devices are used for Type I diabetes, Type II diabetes, and gestational diabetes across various settings, including hospitals, diagnostic centers, home care, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diabetes diagnostics market research report is one of a series of new reports from The Business Research Company that provides diabetes diagnostics market statistics, including the diabetes diagnostics industry global market size, regional shares, competitors with the diabetes diagnostics market share, detailed diabetes diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes diagnostics industry. This diabetes diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes diagnostics market size has grown strongly in recent years. It will grow from $25.39 billion in 2024 to $27.31 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes, expanding geriatric population, increase in sedentary lifestyles, increase in adoption of minimally invasive diagnostic, and rising prevalence of obesity.

The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising adoption of insulin pumps, increasing advancements in diabetes technology, rising in the adoption of unhealthy Lifestyles, surge in the prevalence of type 1 and type 2 diabetes, and expanding healthcare infrastructure. Major trends in the forecast period include advancements in biosensor technology, technological advancements, advancements in diagnostic technologies, personalized medicine and targeted therapies, and advanced technologies in in vitro diagnostic products.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. labs by driving up the cost of High Performance Liquid Chromatography(HPLC) analyzers and calibration standards sourced from Sweden and the Netherlands, exacerbating diabetes screening costs and delaying test results. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of obesity is expected to drive the growth of the diabetes diagnostics market in the coming years. Obesity is characterized by excessive accumulation of body fat, which raises the risk of several health conditions, including heart disease and diabetes. The growing incidence of obesity is linked to factors such as sedentary lifestyles, higher consumption of processed and high-calorie foods, genetic predisposition, and reduced physical activity. Diabetes diagnostics play a crucial role in obesity management by identifying insulin resistance and glucose metabolism issues early, allowing for timely interventions to prevent weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. This increasing obesity rate is contributing to the expansion of the diabetes diagnostics market.

Companies operating in the diabetes diagnostics market are focusing on developing innovative products, such as gestational diabetes diagnostic tools, to broaden their product offerings and meet the rising demand for early detection and management of diabetes during pregnancy. These tools include medical devices and tests designed to detect and monitor gestational diabetes in pregnant women, often involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to evaluate how the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a cutting-edge biosensor tool for detecting insulin resistance-related conditions, including gestational diabetes, endometriosis, and liver disease. This kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation is designed to facilitate early diagnostics, potentially improving health outcomes for millions of patients worldwide.

In September 2023, Abbott Laboratories Ltd., a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition aims to strengthen Abbott's position in diabetes care, expand its FreeStyle Libre portfolio, and advance its efforts in developing connected solutions for more personalized and precise diabetes management. Bigfoot Biomedical Inc. is a US-based medical technology company focused on creating innovative solutions for insulin management.

Major players in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, and DarioHealth Corp.

North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in diabetes diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes diagnostics market consists of revenues earned by entities by providing services such as insulin sensitivity and resistance testing, neuropathy testing services, retinopathy screening services, and diabetes risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes diagnostics market also includes sales of glucose monitoring devices, HbA1c testing kits, and insulin pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types
  • 2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes
  • 3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters
  • 2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices
  • 3) By Lancets: Single-use Lancets; Multi-use Lancets
  • 4) By Test Strips: Standard Test Strips; Smart Test Strips
  • 5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories; Novartis AG; 3M Company; Medtronic plc; Regeneron Pharmaceuticals Inc.; Carl Zeiss Meditec AG; Bausch & Lomb Incorporated; DexCom Inc; Santen Pharmaceutical Co. Ltd.; Topcon Corporation; Tandem Diabetes Care Inc; Ypsomed AG; LifeScan Inc; Nova Biomedical Corporation; Ascensia Diabetes Care Holdings AG; ARKRAY Inc; Optos plc; Bioland Technology Ltd; PTS Diagnostics Inc; AgaMatrix Inc; Senseonics Holdings Inc; DarioHealth Corp.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetes Diagnostics Market Characteristics

3. Diabetes Diagnostics Market Trends And Strategies

4. Diabetes Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diabetes Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Diabetes Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Diabetes Diagnostics Market Growth Rate Analysis
  • 5.4. Global Diabetes Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Diabetes Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Diabetes Diagnostics Total Addressable Market (TAM)

6. Diabetes Diagnostics Market Segmentation

  • 6.1. Global Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Devices
  • Lancets
  • Test Strips
  • Other Product Types
  • 6.2. Global Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes I
  • Diabetes II
  • Gestational Diabetes
  • 6.3. Global Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Other End-Users
  • 6.4. Global Diabetes Diagnostics Market, Sub-Segmentation Of Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Blood Glucose Meters
  • Smart Blood Glucose Meters
  • Bluetooth-enabled Blood Glucose Meters
  • 6.5. Global Diabetes Diagnostics Market, Sub-Segmentation Of Continuous Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable CGM Systems
  • Implantable CGM Systems
  • Flash Glucose Monitoring Devices
  • 6.6. Global Diabetes Diagnostics Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-use Lancets
  • Multi-use Lancets
  • 6.7. Global Diabetes Diagnostics Market, Sub-Segmentation Of Test Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Test Strips
  • Smart Test Strips
  • 6.8. Global Diabetes Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin A1c Testing Kits
  • Urine Glucose Test Strips
  • Blood Ketone Meters

7. Diabetes Diagnostics Market Regional And Country Analysis

  • 7.1. Global Diabetes Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Diabetes Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Diagnostics Market

  • 8.1. Asia-Pacific Diabetes Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Diagnostics Market

  • 9.1. China Diabetes Diagnostics Market Overview
  • 9.2. China Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Diagnostics Market

  • 10.1. India Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Diagnostics Market

  • 11.1. Japan Diabetes Diagnostics Market Overview
  • 11.2. Japan Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Diagnostics Market

  • 12.1. Australia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Diagnostics Market

  • 13.1. Indonesia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Diagnostics Market

  • 14.1. South Korea Diabetes Diagnostics Market Overview
  • 14.2. South Korea Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Diagnostics Market

  • 15.1. Western Europe Diabetes Diagnostics Market Overview
  • 15.2. Western Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Diagnostics Market

  • 16.1. UK Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Diagnostics Market

  • 17.1. Germany Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Diagnostics Market

  • 18.1. France Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Diagnostics Market

  • 19.1. Italy Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Diagnostics Market

  • 20.1. Spain Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Diagnostics Market

  • 21.1. Eastern Europe Diabetes Diagnostics Market Overview
  • 21.2. Eastern Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Diagnostics Market

  • 22.1. Russia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Diagnostics Market

  • 23.1. North America Diabetes Diagnostics Market Overview
  • 23.2. North America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Diagnostics Market

  • 24.1. USA Diabetes Diagnostics Market Overview
  • 24.2. USA Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Diagnostics Market

  • 25.1. Canada Diabetes Diagnostics Market Overview
  • 25.2. Canada Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Diagnostics Market

  • 26.1. South America Diabetes Diagnostics Market Overview
  • 26.2. South America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Diagnostics Market

  • 27.1. Brazil Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Diagnostics Market

  • 28.1. Middle East Diabetes Diagnostics Market Overview
  • 28.2. Middle East Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Diagnostics Market

  • 29.1. Africa Diabetes Diagnostics Market Overview
  • 29.2. Africa Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Diabetes Diagnostics Market Competitive Landscape
  • 30.2. Diabetes Diagnostics Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Diagnostics Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. 3M Company
  • 31.3. Medtronic plc
  • 31.4. Regeneron Pharmaceuticals Inc.
  • 31.5. Carl Zeiss Meditec AG
  • 31.6. Bausch & Lomb Incorporated
  • 31.7. DexCom Inc
  • 31.8. Santen Pharmaceutical Co. Ltd.
  • 31.9. Topcon Corporation
  • 31.10. Tandem Diabetes Care Inc
  • 31.11. Ypsomed AG
  • 31.12. LifeScan Inc
  • 31.13. Nova Biomedical Corporation
  • 31.14. Ascensia Diabetes Care Holdings AG
  • 31.15. ARKRAY Inc

32. Global Diabetes Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Diagnostics Market

34. Recent Developments In The Diabetes Diagnostics Market

35. Diabetes Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Diabetes Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Diabetes Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Diabetes Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer